Skip to main content
Top
Published in: Virchows Archiv 6/2004

01-12-2004 | Original Article

Accuracy of typing and grading invasive mammary carcinomas on core needle biopsy compared with the excisional specimen

Authors: Victor Piana de Andrade, Helenice Gobbi

Published in: Virchows Archiv | Issue 6/2004

Login to get access

Abstract

Introduction

Breast core needle biopsy (CNB) allows evaluation of histological, prognostic, and predictive factors in invasive mammary carcinomas (IMC). We tested the CNB accuracy on typing and grading of invasive breast carcinomas.

Materials and methods

A histological review of 120 CNBs and their related surgical specimens was carried out in a double-blind fashion. Tumor type and grade were assigned according to the World Health Organization classification and the Nottingham grading system.

Results

The sum of CNB fragment lengths varied from 4 mm to 38 mm (mean 16.7 mm), and tumor sample size varied from 1 mm to 26 mm (mean 11.1 mm). Histological type matched surgical specimen evaluation in 80 of 120 cases (66.6%). Of the cases, 17 (14.2%) were changed to a different prognostic category. Histological grade comparison was accurate in 56 of 95 cases (59.0%, kappa=0.35). Histological grade components (tubule formation, nuclear grade, and mitotic index) agreed, respectively, in 54.7%, 58.9%, and 62.1% (kappa index 0.30, 0.36, and 0.28).

Discussion

Typing IMC on CNB can be routinely assessed based on good correlation with surgical specimens, especially considering prognostic categories for IMC. Grading IMC based on CNB is not as accurate, and its evaluation should be delayed until the surgical specimen examination. Tumor heterogeneity seems to be the most important factor for disagreement.
Literature
1.
go back to reference Astall EC, Bobrow LG (1998) Assessment of the accuracy of diagnostic and prognostic information provided by core biopsy in breast carcinoma. J Pathol 186:ssPA6 Astall EC, Bobrow LG (1998) Assessment of the accuracy of diagnostic and prognostic information provided by core biopsy in breast carcinoma. J Pathol 186:ssPA6
2.
go back to reference Boiesen P, Bendahl P, Anagnostaki L, Domanski H, Holm E, Idvall I, Johansson S, Ljungberg O, Ringberg A, Östberg G, Fernö M (2000) Histological grading in breast cancer. Reproducibility between seven pathologic departments. Acta Oncologica 39:41–45CrossRefPubMed Boiesen P, Bendahl P, Anagnostaki L, Domanski H, Holm E, Idvall I, Johansson S, Ljungberg O, Ringberg A, Östberg G, Fernö M (2000) Histological grading in breast cancer. Reproducibility between seven pathologic departments. Acta Oncologica 39:41–45CrossRefPubMed
3.
go back to reference Camp RL, Charaette LA, Rimm DL (2000) Validation of tissue microarray technology in breast carcinoma. Lab Invest 80:1943–1949PubMed Camp RL, Charaette LA, Rimm DL (2000) Validation of tissue microarray technology in breast carcinoma. Lab Invest 80:1943–1949PubMed
5.
go back to reference Cross SS (2000) Correspondence Re: Sharifi S, Peterson MK, Baum JK, Raza S, Schnitt SJ. Assessment of pathological prognostic factors in breast core needle biopsies. Mod Pathol 1999,12(10):941–945. Mod Pathol 13:1332CrossRefPubMed Cross SS (2000) Correspondence Re: Sharifi S, Peterson MK, Baum JK, Raza S, Schnitt SJ. Assessment of pathological prognostic factors in breast core needle biopsies. Mod Pathol 1999,12(10):941–945. Mod Pathol 13:1332CrossRefPubMed
6.
go back to reference Dalton LW, Page DL, Dupont WD (1994) Histologic grading of breast cancer. A reproducibility study. Cancer 73:2765–2770PubMed Dalton LW, Page DL, Dupont WD (1994) Histologic grading of breast cancer. A reproducibility study. Cancer 73:2765–2770PubMed
7.
go back to reference Dalton, LW, Pinder SE, Elston CW, Ellis IO, Page DL, Dupont WD, Blamey RW (2000) Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement. Mod Pathol 13:730–735CrossRefPubMed Dalton, LW, Pinder SE, Elston CW, Ellis IO, Page DL, Dupont WD, Blamey RW (2000) Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement. Mod Pathol 13:730–735CrossRefPubMed
8.
go back to reference Denley H, Pinder SE, Elston CW, Lee AHS, Ellis IO (2000) Needle core biopsy of the breast. Curr Diag Pathol 6:200–205CrossRef Denley H, Pinder SE, Elston CW, Lee AHS, Ellis IO (2000) Needle core biopsy of the breast. Curr Diag Pathol 6:200–205CrossRef
9.
go back to reference Ellis IO, Pinder S (2001) Pitfalls and problems in breast pathology. USCAP 2001 Syllabus. Short Course #10. Handout Ellis IO, Pinder S (2001) Pitfalls and problems in breast pathology. USCAP 2001 Syllabus. Short Course #10. Handout
10.
go back to reference Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW (1992) Pathological prognostic factors in breast cancer. II. Histologic type. Relationship with survival in a large study with long-term follow-up. Histopathology 20:479–489PubMed Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW (1992) Pathological prognostic factors in breast cancer. II. Histologic type. Relationship with survival in a large study with long-term follow-up. Histopathology 20:479–489PubMed
11.
go back to reference Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer—experience from a large study with long-term follow-up. Histopathology 19:403–410PubMed Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer—experience from a large study with long-term follow-up. Histopathology 19:403–410PubMed
12.
go back to reference Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O’Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ (2000) Updated protocol for the examination of specimens from patients with carcinomas of the breast. A basis for checklists. Arch Pathol Lab Med 124:1026–1033PubMed Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O’Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ (2000) Updated protocol for the examination of specimens from patients with carcinomas of the breast. A basis for checklists. Arch Pathol Lab Med 124:1026–1033PubMed
13.
go back to reference Fitzgibbons PL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O’Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ (2000) Prognostic factors in breast cancer. College of American Pathology consensus statement 1999. Arch Pathol Lab Med 124:966–978PubMed Fitzgibbons PL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O’Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ (2000) Prognostic factors in breast cancer. College of American Pathology consensus statement 1999. Arch Pathol Lab Med 124:966–978PubMed
14.
go back to reference Frierson HF, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boye JC, Wilbur DC (1995) Interobserver reproducibility of Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103:195–198PubMed Frierson HF, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boye JC, Wilbur DC (1995) Interobserver reproducibility of Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103:195–198PubMed
15.
go back to reference Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ (1998) Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90:1601–1608CrossRefPubMed Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ (1998) Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90:1601–1608CrossRefPubMed
16.
go back to reference Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (2002) AJCC cancer staging manual, 6th edn. Springer, Berlin Heidelberg New York Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (2002) AJCC cancer staging manual, 6th edn. Springer, Berlin Heidelberg New York
17.
go back to reference Harris GC, Denley HE, Pinder SE, Lee AH, Ellis IO, Elston CW, Evans A (2003) Correlation of histologic prognostic factors in core biopsies and therapeutics excisions of invasive breast carcinoma. Am J Surg Pathol 27:11–15 Harris GC, Denley HE, Pinder SE, Lee AH, Ellis IO, Elston CW, Evans A (2003) Correlation of histologic prognostic factors in core biopsies and therapeutics excisions of invasive breast carcinoma. Am J Surg Pathol 27:11–15
18.
go back to reference Jannink I, Risberg B, Van Diest PJ, Baak JP (1996) Heterogeneity of mitotic activity in breast cancer. Histopathology 29:421–428CrossRefPubMed Jannink I, Risberg B, Van Diest PJ, Baak JP (1996) Heterogeneity of mitotic activity in breast cancer. Histopathology 29:421–428CrossRefPubMed
19.
go back to reference Kronqvist P, Kuopio T, Collan Y (2000) Morphometric grading of breast cancer: thresholds for tubular differentiation. Br J Cancer 82:1656–1661CrossRefPubMed Kronqvist P, Kuopio T, Collan Y (2000) Morphometric grading of breast cancer: thresholds for tubular differentiation. Br J Cancer 82:1656–1661CrossRefPubMed
20.
go back to reference Landis RJ, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMed Landis RJ, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMed
21.
go back to reference Liberman L (1999) Impact of percutaneous imaging-guided core biopsy on the clinical management of breast disease. In: Rosen PP (ed) Breast pathology: diagnosis by needle core biopsy. Lipincott Williams & Wilkins, Philadelphia, pp 291–300 Liberman L (1999) Impact of percutaneous imaging-guided core biopsy on the clinical management of breast disease. In: Rosen PP (ed) Breast pathology: diagnosis by needle core biopsy. Lipincott Williams & Wilkins, Philadelphia, pp 291–300
22.
go back to reference Lind DS, Minter R, Steinbach B, Abbitt P, Lanier L, Haigh L, Vauthey JN, Russin M, Hackett R, Copeland EM (1998) Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer. J Surg Res 78:23–26CrossRefPubMed Lind DS, Minter R, Steinbach B, Abbitt P, Lanier L, Haigh L, Vauthey JN, Russin M, Hackett R, Copeland EM (1998) Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer. J Surg Res 78:23–26CrossRefPubMed
23.
go back to reference Lundin, J, Lundin M, Holli K, Kataja V, Elomaa L, Pylkkänen L, Turpeenniemi-Hujanen T, Joensuu H (2001) Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: results from a nationwide study. J Clin Oncol 19:28–36PubMed Lundin, J, Lundin M, Holli K, Kataja V, Elomaa L, Pylkkänen L, Turpeenniemi-Hujanen T, Joensuu H (2001) Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: results from a nationwide study. J Clin Oncol 19:28–36PubMed
24.
go back to reference Mcllehenny C, Doughty JC, George WD, Mallon EA (2002) Optimal number of core biopsies for accurate assessment of histological grade in breast cancer. Br J Surg 89:84–85CrossRefPubMed Mcllehenny C, Doughty JC, George WD, Mallon EA (2002) Optimal number of core biopsies for accurate assessment of histological grade in breast cancer. Br J Surg 89:84–85CrossRefPubMed
25.
go back to reference Page DL, Simpson JF (2000) Pathology of preinvasive and excellent-prognosis breast cancer Curr Opin Oncol 12:526–531 Page DL, Simpson JF (2000) Pathology of preinvasive and excellent-prognosis breast cancer Curr Opin Oncol 12:526–531
26.
go back to reference Page DL, Jensen RA, Simpson JF (1998) Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat 51:195–208CrossRefPubMed Page DL, Jensen RA, Simpson JF (1998) Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat 51:195–208CrossRefPubMed
27.
go back to reference Parker SH, Jobe WE, Dennis MA, Stavros AT, Johnson KK, Yakes WF, Truell JE, Price JG, Kortz AB, Clark DG (1993) US-guided automated large-core breast biopsy. Radiology 187:507–511PubMed Parker SH, Jobe WE, Dennis MA, Stavros AT, Johnson KK, Yakes WF, Truell JE, Price JG, Kortz AB, Clark DG (1993) US-guided automated large-core breast biopsy. Radiology 187:507–511PubMed
28.
go back to reference Pereira H, Pinder SE, Sibbering DM, Galea MH, Elston CW, Blamey RW, Robertson JFR, Ellis IO (1995) Pathological prognostic factors in breast cancer. IV: Should we be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 27:219–226PubMed Pereira H, Pinder SE, Sibbering DM, Galea MH, Elston CW, Blamey RW, Robertson JFR, Ellis IO (1995) Pathological prognostic factors in breast cancer. IV: Should we be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 27:219–226PubMed
29.
go back to reference Rampaul RS, Pinder SE, Elston CW, Ellis IO (2001) Prognostic and predictive factors in primary breast cancer and their role in patient management: the Nottingham breast team. Eur J Surg Oncol 27:229–238 Rampaul RS, Pinder SE, Elston CW, Ellis IO (2001) Prognostic and predictive factors in primary breast cancer and their role in patient management: the Nottingham breast team. Eur J Surg Oncol 27:229–238
30.
go back to reference Robbins P, Pinder SE, de Klerk N, Dawkins H, Harvey J, Sterrett G, Ellis IO, Elston CW (1995) Histological grading of breast carcinomas. A study of interobserver agreement. Hum Pathol 26:873–879CrossRefPubMed Robbins P, Pinder SE, de Klerk N, Dawkins H, Harvey J, Sterrett G, Ellis IO, Elston CW (1995) Histological grading of breast carcinomas. A study of interobserver agreement. Hum Pathol 26:873–879CrossRefPubMed
31.
go back to reference Sharifi S, Peterson MK, Baum JK, Raza S, Schnitt SJ (1999) Assessment of pathological prognostic factors in breast core needle biopsies. Mod Pathol 12:941–945PubMed Sharifi S, Peterson MK, Baum JK, Raza S, Schnitt SJ (1999) Assessment of pathological prognostic factors in breast core needle biopsies. Mod Pathol 12:941–945PubMed
32.
33.
go back to reference Simon R, Altman G (1994) Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69:979–985PubMed Simon R, Altman G (1994) Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69:979–985PubMed
34.
go back to reference Simpson JF, Page DL (1994) Status of breast cancer prognostication based on histopathologic data. Am J Clin Pathol 102[Suppl 1]:S3–S8 Simpson JF, Page DL (1994) Status of breast cancer prognostication based on histopathologic data. Am J Clin Pathol 102[Suppl 1]:S3–S8
35.
go back to reference Simpson JF, Gray O, Dressler LG, Cobau CD, Falkson CI, Gilchrist KW, Pandya KJ, Page DL, Robert NJ (2000) Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group companion study, EST 4189. J Clin Oncol 18:2059–2069PubMed Simpson JF, Gray O, Dressler LG, Cobau CD, Falkson CI, Gilchrist KW, Pandya KJ, Page DL, Robert NJ (2000) Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group companion study, EST 4189. J Clin Oncol 18:2059–2069PubMed
36.
go back to reference Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Coleman D, Connollu CE, Eusebi V, De Miguel C, Dervan P, Drijkoningen R, Elston CW, Faverly D, Gad A, Jacquemier J, Lacerda M, Martinez-Penuela J, Munt C, Peterse JL, Rank F, Sylvan M, Tsakraklides V, Zafrani B (1999) Consistency achieved by 23 European pathologists from 12 countries in diagnosing disease and reporting prognostic features in carcinomas. Virchows Arch 434:3–10CrossRefPubMed Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Coleman D, Connollu CE, Eusebi V, De Miguel C, Dervan P, Drijkoningen R, Elston CW, Faverly D, Gad A, Jacquemier J, Lacerda M, Martinez-Penuela J, Munt C, Peterse JL, Rank F, Sylvan M, Tsakraklides V, Zafrani B (1999) Consistency achieved by 23 European pathologists from 12 countries in diagnosing disease and reporting prognostic features in carcinomas. Virchows Arch 434:3–10CrossRefPubMed
37.
go back to reference Tavassoli FA, Devilee P (2003) Pathology and genetics of tumors of the breast and female genital organs. IARC WHO Classification of tumors Tavassoli FA, Devilee P (2003) Pathology and genetics of tumors of the breast and female genital organs. IARC WHO Classification of tumors
38.
go back to reference Wong AY, Salisbury E, Bilous M (2000) Recent developments in stereotactic breast biopsy methodologies: an update for the surgical pathologist. Adv Anat Pathol 7:26–35PubMed Wong AY, Salisbury E, Bilous M (2000) Recent developments in stereotactic breast biopsy methodologies: an update for the surgical pathologist. Adv Anat Pathol 7:26–35PubMed
39.
go back to reference Yim JH, Barton P, Weber B, Radford D, Levy J, Monsees B, Flanagan F, Norton JA, Doherty GM (1996) Mammographically detected breast cancer. Benefits of setereotactic core versus wire localization biopsy. Ann Surg 223:688–700CrossRefPubMed Yim JH, Barton P, Weber B, Radford D, Levy J, Monsees B, Flanagan F, Norton JA, Doherty GM (1996) Mammographically detected breast cancer. Benefits of setereotactic core versus wire localization biopsy. Ann Surg 223:688–700CrossRefPubMed
Metadata
Title
Accuracy of typing and grading invasive mammary carcinomas on core needle biopsy compared with the excisional specimen
Authors
Victor Piana de Andrade
Helenice Gobbi
Publication date
01-12-2004
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 6/2004
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-004-1110-5

Other articles of this Issue 6/2004

Virchows Archiv 6/2004 Go to the issue